The Long and Short
Two mergers in financial sector are put on ice
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
New doubts have emerged around Toronto Dominion’s acquisition of First Horizon and Intercontinental Exchange’s acquisition of Black Knight. Both situations require bondholders to focus on the most appropriate course of action. These cases also present a possible window onto the prospects for further M&A in each of their respective industries.
Toronto Dominion (TD: A1/AA-/AA-) recently announced that their long-proposed $13.4 billion acquisition of US regional bank First Horizon (FHN: Baa3+/BBB-*+/BBB*+) would not be able to close by the recently revised date of May 27 and could not at this time provide an accurate timeline for a new closing date. Additional commentary was provided during TD’s fiscal first-quarter earnings call later in the week. Most notably, TD management stated that the company remains committed to deal in the face of increased opposition from regulators.
Intercontinental Exchange’s (ICE: A3/A-) $15.6 billion proposed acquisition of Black Knight (BKI: Ba2*+/BB*+) also has reportedly been challenged by the Federal Trade Commission (FTC), putting its regulatory approval in significant jeopardy. Few additional details are known at this time. However, the completion deadline of June 30 now appears far less likely, raising significant questions for holders of ICE’s bonds with special mandatory redemption language, with a fast-approaching initial trigger date for the mandatory put at an execution price of $101.
Exhibit 1. TD bond curve versus FHN issues outstanding
Source: SanCap, Bloomberg/TRACE BVAL Indications Only
It has now been over a year since FHN agreed to be acquired by TD in a deal that was originally projected to close by the end of the current month. That timeline has once again been pushed back to an unknown date. While regulatory approvals can prove exceptionally difficult in bank mergers of this nature, the deal initially appeared a likely candidate for success on the heels of several notable regional bank mergers over the past several years. With a total asset base of approximately $79 billion as of the end of 2022 and total deposits of roughly $64 billion, FHN appeared large enough to warrant scrutiny but still a deal size that should be imminently do-able from the perspective of regulators. While TD represents one of the pillar banks of Canada with an extraordinarily conservative credit profile, concerns were raised early regarding recent consumer fraud settlements, with Sen. Elizabeth Warren even calling for the transaction to be blocked. Those concerns, along with the complications of a cross-border transaction and future oversight of TD’s increased presence in the US, are likely weighing heavily on the process.
FHN bondholders that are hopeful for debt assumption by TD are best served to maintain their positions, or even consider adding on weakness of the most recent regulatory delay. The more likely outcome still appears a successful completion of the transaction. At worst, if the regulators choose to block the deal, it seems highly probable that FHN could seek another buyer, potentially a larger regional bank within the US, which would still provide considerable upside to bondholders, albeit on what could be a significantly longer-term basis. On a broader scale, a failure to complete this deal as proposed could muddy the landscape for bank M&A, at least for any potential deals that may already be in the works. At a minimum it could certainly spook potential buyers outside the US who might be looking to similarly establish a foothold in the US regional markets.
Exhibit 2. ICE bond curve versus BKI issues outstanding
Source: SanCap, Bloomberg/TRACE BVAL indications only
The ICE acquisition of BKI was announced on May 4 of last year. The proposed financing was set up to be 80% cash and 20% equity. ICE wasted very little time in pre-funding the bulk of the cash financing for the transaction with a public USD debt launch for $8 billion in five tranches, four of which contained $101 Special Mandatory Redemption (SMR) language through May 4, 2023. The indenture language includes two automatic extensions, the first to August 4 and the second to November 4, in the event that “…U.S. antitrust clearance or a related law, injunction, order or other judgment, in each case whether temporary, preliminary or permanent, that restrains, enjoins or otherwise prohibits the consummation of the Merger remains outstanding and all other conditions to closing are satisfied…” Though few details about the FTC challenge have been provided, it would appear likely that the challenge would trigger the automatic extensions, giving ICE the flexibility to gain the necessary approvals until November 4 at the latest. If the process were to drag beyond that date, the issuer also always has the ability to solicit consents of bondholders (typically with a small nominal fee) to postpone the SMR even later.
The SMR bonds have all tightened relative to ICE bonds outstanding without the language as the dollar prices have migrated closer to the $101 put price. Bondholders of those issues are better served to continue holding and await more clarity around the potential challenge from the FTC. Meanwhile, the non-SMR ICE bonds, which would remain outstanding in the event that the BKI transaction were cancelled, do appear to offer good relative value to the SMR counterparts for investors that want to maintain or add exposure to ICE with or without the addition of BKI.
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
